Major Ontario Brain Institute grant fosters collaboration on neurodegenerative brain disorders

May 1, 2014

Drs. Dar Dowlatshahi, David Grimes and Santanu Chakraborty are part of $28.5 million initiative funded by the Ontario Brain Institute to investigate neurodegenerative disorders such as Alzheimer’s disease, Vascular Dementia, Parkinson’s and ALS (Lou Gehrig’s disease). The five year study brings together 54 investigators, 12 clinical sites, 17 universities and hospitals, six industrial partners and 600 patients in an effort to better understand a number of different neurodegenerative brain disorders that afflict people. The hope is that studying several different brain disorders at once will maximize opportunities for breakthrough discoveries. Dr. Grimes is the Ottawa-based Principal Investigator for Parkinson’s disease; while Dr. Dowlatshahi is the Ottawa Principal Investigator for Vascular Cognitive Impairment; and Dr. Chakraborty is the Ottawa Principal Investigator for Neuroradiology. See the news release from the Ontario Brain Institute.

About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.

Media contact
Paddy Moore
Communications and Public Relations
Ottawa Hospital Research Institute
613-737-8899 x73687
613-323-5680 (cell)